$2.92B
$524,000
0.14% of portfolio
4,597
Q4 2024
Reduced 2.36%
$1.19B
$508,000
0.13% of portfolio
12,959
Q4 2024
Reduced 18.8%
$411M
$482,000
0.13% of portfolio
35,602
Q3 2024
Reduced 12.31%
$377M
$480,000
0.13% of portfolio
90,021
Q1 2025
New
$213M
$482,000
0.13% of portfolio
140,251
Q1 2025
Reduced 12.48%
$44.1M
$449,000
0.12% of portfolio
163,555
Q4 2024
Reduced 5.76%
$426M
$457,000
0.12% of portfolio
4,748
Q1 2025
Reduced 9.53%
$3.75B
$451,000
0.12% of portfolio
2,321
Q2 2024
Reduced 0.68%
$95.4M
$461,000
0.12% of portfolio
32,972
Q4 2024
Added 17.88%
$1.6B
$422,000
0.11% of portfolio
9,655
Q4 2024
Reduced 2.35%
$90.9M
$414,000
0.11% of portfolio
48,046
Q4 2024
Reduced 17.93%
$1.73B
$390,000
0.1% of portfolio
5,000
Q1 2025
New
$226M
$358,000
0.1% of portfolio
41,196
Q1 2025
Reduced 3.42%
$1.53B
$366,000
0.1% of portfolio
20,000
Q1 2025
New
$19.3B
$382,000
0.1% of portfolio
10,492
Q2 2024
Reduced 0.7%
$3.94B
$361,000
0.1% of portfolio
5,057
Q4 2024
Reduced 33.08%
$3.56B
$339,000
0.09% of portfolio
47,919
Q2 2024
Reduced 0.7%
$363M
$345,000
0.09% of portfolio
14,143
Q1 2025
Added 16.47%
$64.2B
$337,000
0.09% of portfolio
11,820
Q2 2024
Reduced 0.7%
$99.3M
$311,000
0.08% of portfolio
151,034
Q4 2024
New
$0
$311,000
0.08% of portfolio
3,337
Q1 2025
Reduced 49.72%
$193M
$251,000
0.07% of portfolio
40,000
Q4 2024
Added 68.53%
$1.09B
$266,000
0.07% of portfolio
20,000
Q3 2024
New
$133M
$233,000
0.06% of portfolio
89,631
Q2 2024
Reduced 0.7%
$12.4M
$185,000
0.05% of portfolio
187,700
Q1 2025
New
$6.59B
$179,000
0.05% of portfolio
1,000
Q1 2025
New
$341M
$176,000
0.05% of portfolio
40,877
Q1 2025
New
$17.2B
$193,000
0.05% of portfolio
1,552
Q2 2024
Reduced 0.7%
$10.4B
$202,000
0.05% of portfolio
2,362
Q4 2024
New
$137M
$186,000
0.05% of portfolio
9,198
Q4 2024
New
$8.62B
$198,000
0.05% of portfolio
6,376
Q3 2024
New
$1.07B
$147,000
0.04% of portfolio
10,000
Q1 2025
New
$472M
$150,000
0.04% of portfolio
20,000
Q1 2025
New
$35.6M
$103,000
0.03% of portfolio
65,547
Q1 2025
Reduced 16.0%
$3.04B
$114,000
0.03% of portfolio
2,929
Q1 2025
Reduced 63.06%
$11.1M
$62,000
0.02% of portfolio
55,000
Q1 2025
Reduced 26.67%
$47.5M
$41,000
0.01% of portfolio
14,801
Q1 2025
Reduced 90.0%
$121M
$55,000
0.01% of portfolio
26,200
Q1 2025
New
$71.2M
$34,000
0.01% of portfolio
30,117
Q1 2025
Reduced 78.51%
$10.3M
$21,000
0.01% of portfolio
29,186
Q1 2025
Reduced 88.94%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 51.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 3.1%
Allarity Therapeutics Inc
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.64%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 15.87%
Synchronoss Technologies Inc
-
$0
0.0% of portfolio
-
Q4 2024
New
Transcode Therapeutics Inc
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q4 2024
New